Transcriptomics

Dataset Information

0

Activated T cells break tumor immunosuppression by macrophage re-education


ABSTRACT: Here, we observe that in human and murine melanomas, T-cell activation abates hematopoietic prostaglandin-D2 synthase (HPGDS) transcription in tumor-associated macrophages (TAMs) through TNFα signaling. Mechanistically, HPGDS installs a Prostaglandin-D2 (PGD2) autocrine loop in TAMs via DP1 and DP2 activation that sustains their pro-tumoral phenotype and promotes paracrine inhibition of CD8+ T cells via a PGD2-DP1 axis. Genetic or pharmacologic HPGDS targeting induces anti-tumoral features in TAMs and favors CD8+ T-cell recruitment, activation, and cytotoxicity, altogether sensitizing tumors to αPD1. Conversely, HPGDS overexpression in TAMs or systemic TNFα blockade sustains a pro-tumoral environment and αPD1-resistance, preventing the downregulation of HPGDS by T cells. Congruently, patients and mice resistant to αPD1 fail to suppress HPGDS in TAMs, reinforcing the evidence that circumventing HPGDS is necessary for efficient αPD1 treatment. Overall, we disclose a mechanism whereby T-cell activation controls the innate immune system, and we suggest HPGDS/PGD2 targeting to overcome immunotherapy resistance.

ORGANISM(S): Mus musculus

PROVIDER: GSE281745 | GEO | 2025/03/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-07-22 | GSE84653 | GEO
2016-07-23 | GSE84709 | GEO
2016-07-22 | E-GEOD-84653 | biostudies-arrayexpress
2016-07-23 | E-GEOD-84709 | biostudies-arrayexpress
2012-03-26 | GSE36169 | GEO
2012-03-26 | E-GEOD-36169 | biostudies-arrayexpress
2019-07-26 | GSE134875 | GEO
2024-11-12 | GSE253361 | GEO
2024-11-12 | GSE253356 | GEO
2024-11-12 | GSE262558 | GEO